Literature DB >> 25400990

Quality of care in Crohn's disease.

Govind K Makharia1.   

Abstract

Crohn's disease (CD) is a chronic and progressive inflammatory disease of the intestine. Overall, healthcare delivery for patients with CD is not optimal at the present time and therefore needs improvement. There are evidences which suggest that there is a variation in the care provided to patients with CD by the inflammatory bowel disease (IBD) experts and community care providers. The delivery of healthcare for patients with CD is often complex and requires coordination between gastroenterologists/IBD specialist, gastrointestinal surgeon, radiologists and IBD nurses. In order to improve the quality of health care for patients with CD, there is need that we focus on large-scale, system-wide changes including creation of IBD comprehensive care units, provision to provide continuous care, efforts to standardize care, and education of the community practitioners.

Entities:  

Keywords:  Comprehensive care units; Inflammatory bowel disease; Outcome; Quality assurance; Quality improvement; Quality indicators

Year:  2014        PMID: 25400990      PMCID: PMC4231511          DOI: 10.4291/wjgp.v5.i4.462

Source DB:  PubMed          Journal:  World J Gastrointest Pathophysiol        ISSN: 2150-5330


  32 in total

1.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

Authors:  A Dignass; G Van Assche; J O Lindsay; M Lémann; J Söderholm; J F Colombel; S Danese; A D'Hoore; M Gassull; F Gomollón; D W Hommes; P Michetti; C O'Morain; T Oresland; A Windsor; E F Stange; S P L Travis
Journal:  J Crohns Colitis       Date:  2010-01-15       Impact factor: 9.071

Review 2.  Quality of care delivered to hospitalized inflammatory bowel disease patients.

Authors:  Adam V Weizman; Geoffrey C Nguyen
Journal:  World J Gastroenterol       Date:  2013-10-14       Impact factor: 5.742

3.  World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010.

Authors:  Charles N Bernstein; Michael Fried; J H Krabshuis; Henry Cohen; R Eliakim; Suleiman Fedail; Richard Gearry; K L Goh; Saheed Hamid; Aamir Ghafor Khan; A W LeMair; Qin Ouyang; J F Rey; Ajit Sood; Flavio Steinwurz; Ole O Thomsen; Alan Thomson; Gillian Watermeyer
Journal:  Inflamm Bowel Dis       Date:  2010-01       Impact factor: 5.325

4.  The triple aim: care, health, and cost.

Authors:  Donald M Berwick; Thomas W Nolan; John Whittington
Journal:  Health Aff (Millwood)       Date:  2008 May-Jun       Impact factor: 6.301

5.  Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease.

Authors:  Marietta Iacucci; Subrata Ghosh
Journal:  Therap Adv Gastroenterol       Date:  2011-03       Impact factor: 4.409

Review 6.  Translating improved quality of care into an improved quality of life for patients with inflammatory bowel disease.

Authors:  Corey A Siegel; John I Allen; Gil Y Melmed
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-05       Impact factor: 11.382

7.  Trends in hospitalization rates for inflammatory bowel disease in the United States.

Authors:  Meenakshi Bewtra; Chinyu Su; James D Lewis
Journal:  Clin Gastroenterol Hepatol       Date:  2007-03-26       Impact factor: 11.382

Review 8.  Early use of immunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change.

Authors:  Ingrid Ordás; Brian G Feagan; William J Sandborn
Journal:  Gut       Date:  2011-10-13       Impact factor: 23.059

9.  Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease.

Authors:  Charles M Samson; Pamela Morgan; Elizabeth Williams; Lee Beck; Ricjunette Addie-Carson; Stacy McIntire; Andrea Booth; Eduardo Mendez; Carolyn Luzader; Gitit Tomer; Shehzad Saeed; Edward Donovan; John Bucuvalas; Lee A Denson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-12       Impact factor: 2.839

Review 10.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  Craig Mowat; Andrew Cole; Al Windsor; Tariq Ahmad; Ian Arnott; Richard Driscoll; Sally Mitton; Tim Orchard; Matt Rutter; Lisa Younge; Charlie Lees; Gwo-Tzer Ho; Jack Satsangi; Stuart Bloom
Journal:  Gut       Date:  2011-05       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.